Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
151.36
-2.01 (-1.31%)
Jul 14, 2026, 11:07 AM EDT - Market open

Novartis AG Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
13,52413,86014,35814,83613,62013,55813,17212,87212,12011,77612,09211,74511,04710,96610,78313,08512,81413,52213,36713,294
Revenue Growth (YoY)
-0.70%2.23%9.00%15.26%12.38%15.13%8.93%9.60%9.71%7.39%12.14%-10.24%-13.79%-18.90%-19.33%-1.57%0.95%3.78%6.61%14.39%
Cost of Revenue
3,4593,6113,5393,3223,2273,3243,2343,1733,0963,0223,1173,3422,9913,0412,8743,7513,8563,9763,9383,914
Gross Profit
10,06510,24910,81911,51410,39310,2349,9389,6999,0248,7548,9758,4038,0567,9257,9099,3348,9589,5469,4299,380
Selling, General & Admin
3,1403,4403,3083,4423,0583,5013,1343,0912,8403,4443,0913,0912,8913,1832,9363,5813,5123,9853,6183,754
Research & Development
2,7403,1632,9442,7272,3662,8422,3922,3672,4212,5673,9252,3042,5752,2162,5422,4982,3202,4092,3802,400
Other Operating Expenses
-503066481306361785227390161197201-287716051,027274590198-253
Total Operating Expenses
5,8306,6336,3186,6505,7306,7046,3115,6855,6516,1727,2135,5965,4386,1706,0837,1066,1066,9846,1965,901
Operating Income
4,2353,6164,5014,8644,6633,5303,6274,0143,3732,5821,7622,8072,6181,7551,8262,2282,8522,5623,2333,479
Interest Income
-3-2-4-3-3-3-4-2-29-6-3-2-2-3-5--214,621223239
Interest Expense
-343-304-281-289-270-275-264-246-221-217-222-216-200-207-206-202-201-206-202-201
Other Non-Operating Income (Expense)
-50-92-20-4117332675618158510424-281620-26-24-11
Total Non-Operating Income (Expense)
-396-398-305-333-256-245-242-173-244-205-210-133-98-186-239-186-18314,389-327
Pretax Income
3,8393,2184,1964,5314,4073,2853,3853,8413,1292,3771,5522,6742,5201,5691,5872,0422,66916,9513,2303,506
Provision for Income Taxes
683814266507798465200595441-26139403370254257347450645472611
Net Income
3,1562,4043,9304,0243,6092,8203,1853,2462,6882,6381,5132,2712,1501,3151,3301,6952,21916,3062,7582,895
Minority Interest in Earnings
0-52-1732-4000211021-3-20-1
Earnings From Discontinued Operations
---------5,84225046144151245-----
Net Income to Common
3,1562,4093,9284,0413,6062,8183,1893,2462,6888,4801,7612,3162,2931,4661,5731,6942,22216,3082,7582,896
Net Income Growth
-12.48%-14.51%23.17%24.49%34.15%-66.77%81.09%40.16%17.23%478.44%11.95%36.72%3.19%-91.01%-42.97%-41.51%7.92%678.80%42.53%55.12%
Shares Outstanding (Basic)
1,9091,9131,9261,9481,9681,9872,0122,0332,0442,0502,0622,0832,1102,1352,1672,1982,2252,2372,2372,243
Shares Outstanding (Diluted)
1,9161,9291,9401,9601,9792,0042,0272,0462,0562,0652,0752,0952,1202,1502,1802,2112,2372,2532,2542,258
Shares Change (YoY)
-3.18%-3.74%-4.29%-4.20%-3.74%-2.95%-2.31%-2.34%-3.02%-3.95%-4.82%-5.25%-5.23%-4.57%-3.28%-2.08%-1.24%-1.27%-2.08%-2.00%
EPS (Basic)
1.651.262.042.071.831.421.581.601.314.140.851.111.090.690.730.771.007.291.231.29
EPS (Diluted)
1.651.252.022.061.821.411.571.591.314.110.851.111.080.680.720.770.997.241.221.28
EPS Growth
-9.34%-11.35%28.66%29.56%38.93%-65.69%84.71%43.24%21.30%504.41%18.06%44.16%9.09%-90.61%-40.98%-39.84%8.79%686.96%45.24%58.03%
Free Cash Flow
3,3301,6556,2176,3333,3913,6355,9654,6152,0382,1415,1173,3512,7203,8054,5003,4981,3923,4244,5743,811
Free Cash Flow Growth
-1.80%-54.47%4.23%37.23%66.39%69.78%16.57%37.72%-25.07%-43.73%13.71%-4.20%95.40%11.13%-1.62%-8.21%-26.11%-1.72%58.98%2.36%
Free Cash Flow Per Share
1.740.863.203.231.711.812.942.260.991.042.471.601.281.772.061.580.621.522.031.69
Dividends Per Share
-4.666---3.862---3.919---3.461---3.401--
Dividend Growth
-20.81%----1.44%---13.24%---1.77%---0.29%--
Gross Margin
74.42%73.95%75.35%77.61%76.31%75.48%75.45%75.35%74.46%74.34%74.22%71.55%72.92%72.27%73.35%71.33%69.91%70.60%70.54%70.56%
Operating Margin
31.31%26.09%31.35%32.79%34.24%26.04%27.54%31.18%27.83%21.93%14.57%23.90%23.70%16.00%16.93%17.03%22.26%18.95%24.19%26.17%
Profit Margin
23.34%17.34%27.37%27.12%26.50%20.80%24.18%25.22%22.18%22.40%12.51%19.34%19.46%11.99%12.33%12.95%17.32%120.59%20.63%21.78%
FCF Margin
24.62%11.94%43.30%42.69%24.90%26.81%45.29%35.85%16.82%18.18%42.32%28.53%24.62%34.70%41.73%26.73%10.86%25.32%34.22%28.67%
EBITDA
5,4435,1525,7936,1165,8585,1905,5995,1543,3734,2071,7624,5444,6611,7553,8312,2284,3594,0934,6783,479
EBITDA Margin
40.25%37.17%40.35%41.22%43.01%38.28%42.51%40.04%27.83%35.73%14.57%38.69%42.19%16.00%35.53%17.03%34.02%30.27%35.00%26.17%
EBIT
4,2353,6164,5014,8644,6633,5303,6274,0143,3732,5821,7622,8072,6181,7551,8262,2282,8522,5623,2333,479
EBIT Margin
31.31%26.09%31.35%32.79%34.24%26.04%27.54%31.18%27.83%21.93%14.57%23.90%23.70%16.00%16.93%17.03%22.26%18.95%24.19%26.17%
Effective Tax Rate
17.79%25.30%6.34%11.19%18.11%14.16%5.91%15.49%14.09%-10.98%2.51%15.07%14.68%16.19%16.19%16.99%16.86%3.81%14.61%17.43%
SEC Filings: 10-K · 10-Q